Testosterone DeficiencyNCT04245527
Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)
A study testing Joovv Infrared Light Device in people with Testosterone Deficiency and Estrogen Deficiency, run by ProofPilot at 1 site in United States.
Trial summary
8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Testosterone Deficiency, Estrogen Deficiency
- What is being tested?
- Joovv Infrared Light Device
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- 31 Jan 2020to 1 Jun 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- United States resident
Who cannot join
- current Joovv or other photomodulation therapy user
- under medical supervision for medically treatable illness
- significant travel during study period
- use of birth control
Trial locations and contacts
1 site in 1 country.
United States1 site
ProofPilot (Virtual Study: https://p.proofpilot.com)
New York, New York, 10003
About this study
Official title: Joovvin' for Hormonal Health
8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.
- Conditions
- Testosterone Deficiency, Estrogen Deficiency
- Being tested
- Joovv Infrared Light Device
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Joovv Infrared Light DeviceDevice
Joovv is the leading manufacturer of personal, in-home red light therapy devices
| Study group | Role | What they receive |
|---|---|---|
| Study Arm | Experimental | 20 minutes Joovv Solo every day for 8 weeks. Receives: Device: Joovv Infrared Light Device |
What is being measured
The primary outcome is the main question the study is designed to answer.
Testosterone Change
in males, change from baseline to week 8
Measured: baseline to week 8
change of thyroid-stimulating hormone (TSH)
in females change in estrogen and progesterone from baseline to week 8
Measured: baseline to week 8
Self report general wellness
series of questions at baseline and week 8 on general wellness (modified Short Form-36)
Measured: baseline to week 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jan 2020
- Study start31 Jan 2020 (estimated)
- Primary completion1 May 2020 (estimated)
- Study completion1 Jun 2020 (estimated)
Why it stopped: study cancelled
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Testosterone DeficiencyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Enrolled individuals will receive a Joovv solo for the 8 week study.
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- ProofPilot
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Joovv
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04245527
- Sponsor's protocol ID
- 2216
- Status last verified
- Jan 2020
- First submitted
- 25 Jan 2020
- Last updated
- 17 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No: there is no current plan to make IPD available to other researchers
Study at a glance
From the registry record, last updated by the sponsor on 17 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Joovvin' for Hormonal Health
- ClinicalTrials.gov ID
- NCT04245527
- Acronym / sponsor ID
- 2216
- Conditions
- Testosterone Deficiency, Estrogen Deficiency
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: study cancelled
- Enrolment
- 0 participants (actual)
- Lead sponsor
- ProofPilotIndustry (pharma, biotech, devices)
- Collaborators
- Joovv
- Study start
- 31 Jan 2020 (estimated)
- Primary completion
- 1 May 2020 (estimated)
- Study completion
- 1 Jun 2020 (estimated)
- First posted
- 29 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Enrolled individuals will receive a Joovv solo for the 8 week study.
| Arm | Type | Receives |
|---|---|---|
| Study Arm | Experimental | Device: Joovv Infrared Light Device20 minutes Joovv Solo every day for 8 weeks. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- United States resident
Key exclusion criteria (4 listed)
- current Joovv or other photomodulation therapy user
- under medical supervision for medically treatable illness
- significant travel during study period
- use of birth control
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Joovv Infrared Light DeviceJoovv is the leading manufacturer of personal, in-home red light therapy devices | Device | Study Arm |
Primary outcome
Testosterone Change
Time frame: baseline to week 8
in males, change from baseline to week 8
change of thyroid-stimulating hormone (TSH)
Time frame: baseline to week 8
in females change in estrogen and progesterone from baseline to week 8
Self report general wellness
Time frame: baseline to week 8
series of questions at baseline and week 8 on general wellness (modified Short Form-36)
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Sep 2026.
- Individual participant dataSharing planned: No. there is no current plan to make IPD available to other researchers
Related trials for Testosterone Deficiency
RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Hypogonadism, Male
Enrolling by invitation
AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism
Hypogonadism, Male, Secondary Hypogonadism
Not yet recruiting
Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause
Menopause, Sexual Dysfunction
RecruitingPhase 2
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Metastatic Prostate Cancer
RecruitingObservational study
Anthropometric, Functional and Lifestyle Factors Associated With Testosterone Levels in Middle-Aged Men
Testosterone Deficiency, Male Hypogonadism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Joovv Infrared Light Device in people with Testosterone Deficiency and Estrogen Deficiency, run by ProofPilot at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Testosterone Change (time frame: baseline to week 8). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.